KLAC vs SILO · P/E 55, rev $13.58B vs rev $18.0K
KLA Corporation (KLAC) versus Silo Pharma Inc (SILO) — a side-by-side from cached financials, not a winner call.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US.
Silo Pharma Inc (SILO) is a biotechnology company listed on US.
Latest reported KLAC revenue for 2026-06-30 was $13.58B. Net income was $4.83B. Revenue was up 11.7% from 2025-06-30 to 2026-06-30. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Latest reported SILO revenue for 2026-06-30 was $18.0K. Net income was -$2.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SILO currently screens at market cap $4.4M.
KLAC currently screens at market cap $252.01B and trailing P/E 54.7. SILO currently screens at market cap $4.4M.
Not investment advice. Open the KLAC and SILO stock pages for the full models.
Not investment advice.